Considering that species in Fusobacterium genus was one of the mucosal bacteria that promoted tumor development, this could partially explain why the chemokine CXCL9 could not serve as a powerful independent predictor of our CRC patient survival. The gene discussed is CXCL9; the disease is neoplasm.